The Bioverge mission is to accelerate the development of solutions for intractable problems in healthcare. We accomplish this by democratizing the access, tools, and resources necessary to invest in and advance the most innovative emerging companies in the space.
The Bioverge platform is healthcare-focused and enables everyone, from family offices to investment advisors to accredited and non-accredited individuals, to invest in highly vetted healthcare startups at the cutting edge of innovation, and actively support each along their journey to transform healthcare.
- Min investment
- Days Left
San Francisco, CA
- Security Type
Common stock is a security that represents ownership in a corporation.
- April 28, 2021
- May 07, 2021
- Valuation Cap
CrowdLustro Research Report
Use of Proceeds
General & administrative-$428,043, 40.0%
Product development-$321,032, 30.0%
Sales & marketing-$268,494, 25.1%
Intermediary fees-$52,430, 4.9%
Executive Leadership Team at $3B venture philanthropy organization. Formerly Vice President of Business Development at Notable Labs. Advisor on investment banking transactions totaling $1B+.
Rick Gibb, Founder, COO & Managing Director
Investment professional at Stanford’s $450M healthcare venture capital fund. Maintained portfolio of 300+ healthcare inventions at Stanford.
No reports have been submittedBecome a Reporter